Targeted Medical (TRGM) 0.0121 $TRGM
Targeted Medical Pharma Combats the Epidemic of Pain with Release of THERALEVE(TM)
BusinessWire - Wed Mar 16, 12:00PM CDT
Targeted Medical Pharma, Inc. (OTCQB: TRGM) in conjunction with Amino Nutritionals LLC, today announced the consumer release of THERALEVE(TM) (www.theralevehealth.com) a patented amino acid based formula designed by pain management physicians to help the 100 million chronic pain sufferers in the United States, fight pain and inflammation without the dangerous side effects commonly associated with NSAIDs and opioids.
Targeted Medical Pharma enters into exclusive distribution agreement in China with Healthy Focus Limited
M2 - Thu Jan 14, 4:38AM CST
Targeted Medical Pharma (Other OTC:TRGM) reported on Wednesday that it has entered into an exclusive health product licensing agreement with Healthy Focus Limited based in Hong Kong.
Targeted Medical Pharma Finalizes Exclusive Agreement for Distribution in China
BusinessWire - Wed Jan 13, 12:00PM CST
Targeted Medical Pharma (OTCQB: TRGM), today announced the completion of an exclusive product licensing agreement with Healthy Focus Limited, a Hong Kong based company that specializes in distributing healthcare products throughout China.
Targeted Medical Pharma Breaks Ground in the Consumer Goods Market
BusinessWire - Thu Dec 03, 12:00PM CST
Targeted Medical Pharma, Inc. (OTCQB: TRGM), announced the establishment of a new subsidiary, Amino Nutritionals LLC, that will specialize in the development and marketing of THERALEVE(TM), a proprietary consumer product for chronic pain sufferers to be sold in the United States and abroad.
Tauriga Sciences, Inc. Appoints Mr. Seth M. Shaw to Positions of Chairman and Chief Executive Officer and Ms. Ghalia Lahlou as Interim Chief Financial Officer Effective Immediately
PR Newswire - Mon Jul 13, 7:00AM CDT
Tauriga Sciences, Inc. (OTCQB: TAUG) or ("Tauriga" or "the Company"
, a diversified life sciences company, today announced the appointments of Mr. Seth M. Shaw as Chairman of the Board of Directors ("Chairman" and Chief Executive Officer ("CEO" and Ms. Ghalia Lahlou as Interim Chief Financial Officer ("Interim CFO". Ms. Lahlou will maintain her current position as Corporate Secretary ("Secretary" as well. The outgoing CEO, Dr. Stella M. Sung will continue to support the Company in the important role of Chairman of the Medical Advisory Board.
UNXL: 1.56 (+0.04), LTBR: 0.39 (+0.03)
New Research from Targeted Medical Pharma Finds a Link Between Obesity and Nutritional Deficiencies
BusinessWire - Mon Apr 27, 2:00PM CDT
Obesity has reached epidemic proportions affecting nearly 78 million adults in the United States and has been linked with an increased risk of diabetes, heart disease, and cancer. Recent studies have suggested that obese patients have specific amino acid deficiencies that can contribute to obesity.
Targeted Medical Pharma Announces Changes in Management and Board of Directors
BusinessWire - Thu Jan 29, 11:00AM CST
Targeted Medical Pharma, Inc. (OTCQB: TRGM), today announced several major changes that streamline operations and signify a commitment to revenue growth, cost containment and profitability. The Company has appointed Kim Giffoni, a co-founder and former Vice President of Foreign Sales at Targeted Medical Pharma, as the Chief Executive Officer. Dr. David Silver, former Chief Operating Officer and President at the Company, has been appointed Chief Medical Officer, and Marcus Charuvastra, the Director of Marketing, takes over as Vice President of Operations and Marketing.
Targeted Medical Pharma, Inc. - "Targeted Medical Pharma Third Quarter Recap"
ACCESSWIRE - Wed Dec 03, 2:01PM CST
NEW YORK, NY / ACCESSWIRE / December 3, 2014 / Targeted Medical Pharma, Inc. (OTCQB: TRGM) today published a new blog post on The Chairman's Blog, written by the Company's CEO and CSO, Dr. William Shell. TheChairmansBlog.com is an exclusive online media publication that enables key executive officers a unique platform to share insights about their company and industry trends.
Targeted Medical Pharma Inc. "Treatment Update: Medical Foods for the Treatment of PTSD"
ACCESSWIRE - Mon Nov 03, 7:16AM CST
New York, NY / ACCESSWIRE / November 3, 2014 / Targeted Medical Pharma, Inc. (OTCQB: TRGM) today published a new blog post on The Chairman's Blog, written by the Company's CEO and CSO, Dr. William Shell. TheChairmansBlog.com is an exclusive online media publication that enables key executive officers a unique platform to share insights about their company and industry trends.
Targeted Medical Pharma Releases Promising Trial Results for the Treatment of Posttraumatic Stress Disorder
BusinessWire - Mon Oct 13, 5:00PM CDT
Targeted Medical Pharma, Inc. (OTCQB: TRGM), a drug discovery and development company, today announced the results of a clinical trial studying the amino acid based medical foods, Sentra AM and Sentra PM in Veterans suffering from symptoms associated with Posttraumatic Stress Disorder (PTSD).
Targeted Medical Pharma - "Developing New Therapies for Chronic Pain"
ACCESSWIRE - Tue Oct 07, 8:24AM CDT
New York, NY / October 7, 2014 / Targeted Medical Pharma, Inc. (OTCQB: TRGM) today published a new blog post on The Chairman's Blog, written by the Company's President and Chief Operating Officer, Dr. David Silver. TheChairmansBlog.com is an exclusive online media publication that enables key executive officers a unique platform to share insights about their company and industry trends.
Targeted Medical Pharma's New Approach to Pain Management Targets Epidemic of Opioid and NSAID Over-Prescribing
BusinessWire - Mon Oct 06, 5:00PM CDT
Targeted Medical Pharma, Inc. (OTCQB: TRGM) recently published the White Paper: Innovations in Pain Management discussing the epidemic of pain, the dangers of commonly prescribed pain medications and the benefits of Theramine as a clinically effective alternative to opioids and nonsteroidal anti-inflammatory (NSAID) drugs for the management of back pain and inflammation.
Targeted Medical Pharma Combats the Epidemic of Pain with Release of THERALEVE(TM)
BusinessWire - Wed Mar 16, 12:00PM CDT
Targeted Medical Pharma, Inc. (OTCQB: TRGM) in conjunction with Amino Nutritionals LLC, today announced the consumer release of THERALEVE(TM) (www.theralevehealth.com) a patented amino acid based formula designed by pain management physicians to help the 100 million chronic pain sufferers in the United States, fight pain and inflammation without the dangerous side effects commonly associated with NSAIDs and opioids.
Targeted Medical Pharma enters into exclusive distribution agreement in China with Healthy Focus Limited
M2 - Thu Jan 14, 4:38AM CST
Targeted Medical Pharma (Other OTC:TRGM) reported on Wednesday that it has entered into an exclusive health product licensing agreement with Healthy Focus Limited based in Hong Kong.
Targeted Medical Pharma Finalizes Exclusive Agreement for Distribution in China
BusinessWire - Wed Jan 13, 12:00PM CST
Targeted Medical Pharma (OTCQB: TRGM), today announced the completion of an exclusive product licensing agreement with Healthy Focus Limited, a Hong Kong based company that specializes in distributing healthcare products throughout China.
Targeted Medical Pharma Breaks Ground in the Consumer Goods Market
BusinessWire - Thu Dec 03, 12:00PM CST
Targeted Medical Pharma, Inc. (OTCQB: TRGM), announced the establishment of a new subsidiary, Amino Nutritionals LLC, that will specialize in the development and marketing of THERALEVE(TM), a proprietary consumer product for chronic pain sufferers to be sold in the United States and abroad.
Tauriga Sciences, Inc. Appoints Mr. Seth M. Shaw to Positions of Chairman and Chief Executive Officer and Ms. Ghalia Lahlou as Interim Chief Financial Officer Effective Immediately
PR Newswire - Mon Jul 13, 7:00AM CDT
Tauriga Sciences, Inc. (OTCQB: TAUG) or ("Tauriga" or "the Company"
, a diversified life sciences company, today announced the appointments of Mr. Seth M. Shaw as Chairman of the Board of Directors ("Chairman" and Chief Executive Officer ("CEO" and Ms. Ghalia Lahlou as Interim Chief Financial Officer ("Interim CFO". Ms. Lahlou will maintain her current position as Corporate Secretary ("Secretary" as well. The outgoing CEO, Dr. Stella M. Sung will continue to support the Company in the important role of Chairman of the Medical Advisory Board. UNXL: 1.56 (+0.04), LTBR: 0.39 (+0.03)
New Research from Targeted Medical Pharma Finds a Link Between Obesity and Nutritional Deficiencies
BusinessWire - Mon Apr 27, 2:00PM CDT
Obesity has reached epidemic proportions affecting nearly 78 million adults in the United States and has been linked with an increased risk of diabetes, heart disease, and cancer. Recent studies have suggested that obese patients have specific amino acid deficiencies that can contribute to obesity.
Targeted Medical Pharma Announces Changes in Management and Board of Directors
BusinessWire - Thu Jan 29, 11:00AM CST
Targeted Medical Pharma, Inc. (OTCQB: TRGM), today announced several major changes that streamline operations and signify a commitment to revenue growth, cost containment and profitability. The Company has appointed Kim Giffoni, a co-founder and former Vice President of Foreign Sales at Targeted Medical Pharma, as the Chief Executive Officer. Dr. David Silver, former Chief Operating Officer and President at the Company, has been appointed Chief Medical Officer, and Marcus Charuvastra, the Director of Marketing, takes over as Vice President of Operations and Marketing.
Targeted Medical Pharma, Inc. - "Targeted Medical Pharma Third Quarter Recap"
ACCESSWIRE - Wed Dec 03, 2:01PM CST
NEW YORK, NY / ACCESSWIRE / December 3, 2014 / Targeted Medical Pharma, Inc. (OTCQB: TRGM) today published a new blog post on The Chairman's Blog, written by the Company's CEO and CSO, Dr. William Shell. TheChairmansBlog.com is an exclusive online media publication that enables key executive officers a unique platform to share insights about their company and industry trends.
Targeted Medical Pharma Inc. "Treatment Update: Medical Foods for the Treatment of PTSD"
ACCESSWIRE - Mon Nov 03, 7:16AM CST
New York, NY / ACCESSWIRE / November 3, 2014 / Targeted Medical Pharma, Inc. (OTCQB: TRGM) today published a new blog post on The Chairman's Blog, written by the Company's CEO and CSO, Dr. William Shell. TheChairmansBlog.com is an exclusive online media publication that enables key executive officers a unique platform to share insights about their company and industry trends.
Targeted Medical Pharma Releases Promising Trial Results for the Treatment of Posttraumatic Stress Disorder
BusinessWire - Mon Oct 13, 5:00PM CDT
Targeted Medical Pharma, Inc. (OTCQB: TRGM), a drug discovery and development company, today announced the results of a clinical trial studying the amino acid based medical foods, Sentra AM and Sentra PM in Veterans suffering from symptoms associated with Posttraumatic Stress Disorder (PTSD).
Targeted Medical Pharma - "Developing New Therapies for Chronic Pain"
ACCESSWIRE - Tue Oct 07, 8:24AM CDT
New York, NY / October 7, 2014 / Targeted Medical Pharma, Inc. (OTCQB: TRGM) today published a new blog post on The Chairman's Blog, written by the Company's President and Chief Operating Officer, Dr. David Silver. TheChairmansBlog.com is an exclusive online media publication that enables key executive officers a unique platform to share insights about their company and industry trends.
Targeted Medical Pharma's New Approach to Pain Management Targets Epidemic of Opioid and NSAID Over-Prescribing
BusinessWire - Mon Oct 06, 5:00PM CDT
Targeted Medical Pharma, Inc. (OTCQB: TRGM) recently published the White Paper: Innovations in Pain Management discussing the epidemic of pain, the dangers of commonly prescribed pain medications and the benefits of Theramine as a clinically effective alternative to opioids and nonsteroidal anti-inflammatory (NSAID) drugs for the management of back pain and inflammation.
